2015 AHA/ASA Focused Update Guidelines for Acute Ischemic Stroke Regarding Endovascular Treatment

2015 AHA/ASA Focused Update Guidelines for Acute Ischemic Stroke Regarding Endovascular Treatment

• 1.
  The American Academyof Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2015;46:3020-3035. 2015 AHA/ASA Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment A Guideline for Healthcare Professionals From the AHA/ASA
• 2.
  ENDOVASCULAR INTERVENTIONS
• 3.
  Patients eligible forIV r-tPA should receive IV r-tPA even if endovascular treatments are being considered (Class I). (Unchanged from the 2013 guideline)
• 4.
  Patients should receiveendovascular therapy with a stent retriever if they meet all the following criteria (Class I). (New recommendation): – pre-stroke Modified Rankin Scale score 0 to 1 – acute ischemic stroke receiving IV r-tPA within 4.5 hours of onset according to guidelines from professional medical societies – causative occlusion of the ICA or proximal MCA – age ≥18 years – NIHSS score of ≥6 – Alberta Stroke Program Early CT score (ASPECTS) ≥6 – treatment can be initiated (groin puncture) within 6 hours of symptom onset
• 5.
  As with IVr-tPA, reduced time from symptom onset to reperfusion with endovascular therapies is highly associated with better clinical outcomes. To ensure benefit, reperfusion to Thrombolysis in Cerebral Infarction (TICI) scale grade 2b/3 should be achieved as early as possible and within 6 hours of stroke onset (Class I). (Revised from the 2013 guideline)
• 6.
  In carefully selectedpatients with anterior circulation occlusion who have contraindications to IV r-tPA, endovascular therapy with stent retrievers completed within 6 hours of stroke onset is reasonable (Class IIa).
• 7.
  Observing patients afterIV r-tPA to assess for clinical response before pursuing endovascular therapy is not required to achieve beneficial outcomes and is not recommended. (Class III). (New recommendation)
• 8.
  Initial treatment withIA fibrinolysis is beneficial for carefully selected patients with major ischemic strokes of <6 hours’ duration caused by occlusions of the MCA (Class I). A clinically beneficial dose of IA tPA is not established, and tPA does not have FDA approval for IA use. As a consequence, endovascular therapy with stent retrievers is recommended over IA fibrinolysis as first-line therapy (Class I). (Revised from the 2013 guideline)
• 9.
  IMAGING
• 10.
  Emergency imaging ofthe brain is recommended before initiating any specific treatment for acute stroke (Class I). In most instances, non-enhanced CT will provide the necessary information to make decisions about emergency management. (Unchanged from the 2013 guideline)
• 11.
  If endovascular therapyis contemplated, a non- invasive intracranial vascular study is strongly recommended during the initial imaging evaluation of the acute stroke patient but should not delay IV tPA if indicated. For patients who qualify for IV tPA according to guidelines from professional medical societies, initiating IV tPA before non-invasive vascular imaging is recommended for patients who have not had non-invasive vascular imaging as part of their initial imaging assessment for stroke. Non-invasive intracranial vascular imaging should then be obtained as quickly as possible (Class I). (New recommendation)
• 12.
  QUESTION